Guru Ownership Trend
Guru Analysis for DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $23.45 M.
Top institutional holders include Leon Cooperman and Private Capital.
Institutional sentiment is currently Bullish. This is evidenced by a $9.71 M net inflow during the quarter.
Recent activity highlights Leon Cooperman who increased their stake by 70.8%. Conversely, Cliff Asness reduced exposure by 1.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for DiaMedica Therapeutics Inc. (DMAC)
Major holders include Leon Cooperman ($24.29 M), Private Capital ($352,000), Cliff Asness ($78,333). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.51 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.71 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited DMAC. The total reported sell value was $356,707.38.
Yes, 0 managers opened new positions in DMAC, and 1 increased their existing holdings. The total reported buy value was $10.07 M.